Primary prophylaxis of cryptococcal disease using fluconazole in HIV positive Ugandan adults - a double blind, randomised, placebo controlled trial

BACKGROUND: Cryptococcal disease remains an important cause of morbidity and mortality in HIV infected individuals in sub-Saharan Africa, despite the introduction of antiretroviral therapy (ART). Fluconazole has not been previously studied as primary prophylaxis against cryptococcal disease in patie...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Infect Dis
Auteurs principaux: Parkes-Ratanshi, Rosalind, Wakeham, Katie, Levin, Jonathan, Namusoke, Deodata, Whitworth, James, Coutinho, Alex, Mugisha, Nathan Kenya, Grosskurth, Heiner, Kamali, Anatoli, Lalloo, David G
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856956/
https://ncbi.nlm.nih.gov/pubmed/21982529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(11)70245-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires